Wang Xiaoqian, Wei Yinxiang, Xiao He, Liu Xiaoling, Zhang Yu, Han Gencheng, Chen Guojiang, Hou Chunmei, Zhang Li, Ma Ning, Shen Beifen, Li Yan, Egwuagu Charles E, Wang Renxi
Laboratory of Immunology, Institute of Basic Medical Sciences, Beijing 100850, China.
Laboratory of Immunology, Institute of Basic Medical Sciences, Beijing 100850, China; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310013, China.
Mol Immunol. 2016 Mar;71:54-63. doi: 10.1016/j.molimm.2016.01.011. Epub 2016 Feb 4.
Interleukin 10 (IL-10)-producing regulatory B-cells (Bregs) suppress inflammatory responses that mediate autoimmune diseases. However, it is unknown whether Bregs derive from a pre-existing dedicated B-cell lineage or if any B-cell can differentiate into Bregs in response to BCR or TLR activation. GL7(+) B-cells are antigen-experienced differentiated B-cells while GL7(-/lo) are at an early stage of B-cell differentiation. While both GL7(-/lo) and GL7(+) B cells can produce IL-10, differentiation of GL7(-) B-cells into Bregs does not require CD19- or Bcl6-induced signals, suggesting that BCR-induced proliferation or Ig class-switching is not necessary for generation of Breg cells. Of particular importance, we show that GL7(-) Breg cells are dramatically expanded in lupus-like mice and GL7(-) Bregs suppressed inflammatory responses in lupus-like mice by inducing expansion of Foxp3(+)Treg cells. Taken together, these results suggest that pre-existing GL7(-)IL-10(+) cells are expanded during inflammation, differentiate into GL7(+) Bregs and contribute to immune-regulation in lupus-like mice.
产生白细胞介素10(IL-10)的调节性B细胞(Bregs)可抑制介导自身免疫性疾病的炎症反应。然而,尚不清楚Bregs是源自预先存在的特定B细胞谱系,还是任何B细胞都能在BCR或TLR激活后分化为Bregs。GL7(+) B细胞是经历过抗原刺激的分化B细胞,而GL7(-/lo) B细胞处于B细胞分化的早期阶段。虽然GL7(-/lo)和GL7(+) B细胞都能产生IL-10,但GL7(-) B细胞向Bregs的分化并不需要CD19或Bcl6诱导的信号,这表明BCR诱导的增殖或Ig类别转换对于Breg细胞的产生并非必要。特别重要的是,我们发现GL7(-) Breg细胞在狼疮样小鼠中显著扩增,并且GL7(-) Bregs通过诱导Foxp3(+)Treg细胞的扩增来抑制狼疮样小鼠中的炎症反应。综上所述,这些结果表明,预先存在的GL7(-)IL-10(+)细胞在炎症过程中扩增,分化为GL7(+) Bregs,并有助于狼疮样小鼠的免疫调节。